Enalaprilat (Compound)

Synonyms:Enalaprilat, 76420-72-9, Enalapril acid, Enalaprilate, Enalaprilatum, Enalapril diacid, Enalaprilic acid, Enalaprilat anhydrous, (S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline, enalaprilat (anhydrous), MK-422, UNII-Q508Q118JM, Enalaprilat hydrate, CHEBI:4786, Q508Q118JM, 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE, ((S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline, MFCD00865786, EAL, L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-, ENALAPRILAT INHIBITOR, (2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid, SMR000466359, enalaprilat [Spanish], MK 421 diacid, CHEMBL577, Enalaprilate [French], Enalaprilatum [Latin], MK 422, L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-, Enalaprilat,(S), (S)-1-((S)-2-((S)-1-carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carboxylic acid, (2S)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]pyrrolidine-2-carboxylic acid, EINECS 278-459-3, Enalaprilat [INN], Enalapril impurity C, SCHEMBL37289, (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid, MLS000759476, MLS001424138, BIDD:GT0752, GTPL6332, N-(1(S)-Carboxy-3-phenylpropyl)-L-alanyl-L-proline, Enalaprilat, analytical standard, DTXSID0048975, HMS2051H16, HMS2089P04, HMS2232B19, HMS3263O13, Pharmakon1600-01503833, ZINC3812851, Tox21_501036, BDBM50367254, NSC760053, AKOS015840130, AKOS015892570, CCG-101042, DB09477, LP01036, MCULE-3507396113, NC00292, NSC-760053, SDCCGSBI-0633781.P001, NCGC00164593-01, NCGC00164593-11, NCGC00261721-01, AS-13013, E1302, AB00698268-05, AB00698268-07, AB00698268-08, AB00698268_09, AB00698268_10, 420E729, SR-01000763426, Q5375179, SR-01000763426-3, W-104365, N-[(s)-1-carboxy-3-phenyl-propyl]-l-alanyl-l-proline, L-Proline, 1-(N-(1-carboxt-3-phenylpropyl)-L-alanyl)-, (S)-, (2S)-1-[(2S)-2-[[(1S)-1-CARBOXY-3-PHENYL-PROPYL]AMINO]PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID, (2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic Acid (Enalaprilat)

Pubchem:PUBCHEM:5462501

Id:5462501

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Enalaprilat's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Enalaprilat.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Enalaprilat.

Results found

Linked to

	Label	Description
	enalaprilat negatively regulates PTX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat negatively regulates HOXB2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat positively regulates SQLE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat positively regulates DHRS2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat negatively regulates CXCL8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat negatively regulates CA2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat in similarity relationship with A-769662 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat positively regulates G3BP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat positively regulates DDAH1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	enalaprilat in similarity relationship with Famprofazone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS